Your shopping cart is currently empty

EGFR-IN-71 is a potent inhibitor of epidermal growth factor receptor (EGFR) with an IC50 of 3.7 μM, and it has research value in chordoma.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $1,980 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $2,500 | 8-10 weeks | 8-10 weeks |
| Description | EGFR-IN-71 is a potent inhibitor of epidermal growth factor receptor (EGFR) with an IC50 of 3.7 μM, and it has research value in chordoma. |
| In vitro | EGFR-IN-71 (also known as compound 41) demonstrated inhibitory effects on various chordoma cell lines including U-CH1, U-CH2, CH22, UM-Chor1, U-CH12, and U-CH7 when tested at concentrations ranging from 0-100 μM over a period of 72 hours. This activity was quantitatively assessed using a Cell Viability Assay, which revealed that the compound effectively reduced the viability of these cell lines with half-maximal inhibitory concentration (IC50) values of 9.1 μM, 16 μM, 0.48 μM, 25 μM, 0.96 μM, and 8.0 μM, respectively. |
| Molecular Weight | 405.62 |
| Formula | C16H9ClIN3 |
| Cas No. | 2676155-98-7 |
| Smiles | N(C=1C2=C(N=CN1)C=C(I)C=C2)C3=CC(C#C)=C(Cl)C=C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.